Shopping Cart
- Remove All
- Your shopping cart is currently empty
Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is an E3 ligase ligand-linker conjugate developed using a Thalidomide-based cereblon ligand and a 3-unit PEG linker, synthesized specifically for use in PROTAC technology.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder |
Description | Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is an E3 ligase ligand-linker conjugate developed using a Thalidomide-based cereblon ligand and a 3-unit PEG linker, synthesized specifically for use in PROTAC technology. |
In vitro | Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3), comprising a Degron (E3 ubiquitin ligase) and a linker, is employed in PROTAC technology to degrade target proteins like BRD4, BRD2, and BRD3 by binding to the targeting ligand[1]. |
Alias | E3 Ligase Ligand-Linker Conjugates 14, Cereblon Ligand-Linker Conjugates 3 |
Molecular Weight | 506.51 |
Formula | C23H30N4O9 |
Cas No. | 1957236-20-2 |
Relative Density. | 1.358 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.